BioCentury | May 30, 2019
Financial News

May 30 Financial Quick Takes: $200M series F for Tempus; plus TFF, Frontage Holdings

...and of Bios Partners. Frontage Holdings gains in first day of Hong Kong trading CRO Frontage Holdings Corp....
BioCentury | Jul 17, 2018
Financial News

CanSino latest to file for HKEX IPO

...HKEX’s pre-revenue biotech chapter including: AOBiome Therapeutics Inc. (Cambridge, Mass.), Stealth BioTherapeutics Corp. (Newton, Mass.), Frontage Holdings Corp....
BioCentury | Sep 1, 2014
Company News

Frontage Laboratories, Tigermed deal

...position in fellow CRO Frontage, which will continue to operate independently (see BioCentury, May 12). Frontage Laboratories...
BioCentury | May 12, 2014
Company News

Frontage Laboratories, Tigermed deal

...reported 2013 revenues of RMB335 million ($55.3 million), while Frontage declined to disclose 2013 revenues. Frontage Laboratories...
Items per page:
1 - 4 of 4
BioCentury | May 30, 2019
Financial News

May 30 Financial Quick Takes: $200M series F for Tempus; plus TFF, Frontage Holdings

...and of Bios Partners. Frontage Holdings gains in first day of Hong Kong trading CRO Frontage Holdings Corp....
BioCentury | Jul 17, 2018
Financial News

CanSino latest to file for HKEX IPO

...HKEX’s pre-revenue biotech chapter including: AOBiome Therapeutics Inc. (Cambridge, Mass.), Stealth BioTherapeutics Corp. (Newton, Mass.), Frontage Holdings Corp....
BioCentury | Sep 1, 2014
Company News

Frontage Laboratories, Tigermed deal

...position in fellow CRO Frontage, which will continue to operate independently (see BioCentury, May 12). Frontage Laboratories...
BioCentury | May 12, 2014
Company News

Frontage Laboratories, Tigermed deal

...reported 2013 revenues of RMB335 million ($55.3 million), while Frontage declined to disclose 2013 revenues. Frontage Laboratories...
Items per page:
1 - 4 of 4